Drug-induced tendinopathy: From physiology to clinical applications

Joint Bone Spine

Volumn 81, Issue 6, 2014, Pages 485-492

  Kirchgesner, Thomas ^a   Larbi, Ahmed ^a   Omoumi, Patrick ^a   Malghem, Jacques ^a   Zamali, Nadia ^a   Manelfe, Julien ^b   Lecouvet, Frédéric ^a   Vande Berg, Bruno ^a   Djebbar, Sahlya ^c   Dallaudière, Benjamin ^a,d  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b BICHAT HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Glucocorticoid; Iatrogenic; Quinolone; Statin; Tendinopathy; Tendon

Indexed keywords

ANABOLIC AGENT; ANTIRETROVIRUS AGENT; AROMATASE INHIBITOR; COLLAGEN; CYCLOOXYGENASE 2; GLUCOCORTICOID; HYDROXYAPATITE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; ISOTRETINOIN; PROSTAGLANDIN E2; QUINOLONE; STROMELYSIN; QUINOLONE DERIVATIVE;

BIOMECHANICS; COLLAGEN FIBER; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DRUG INDUCED DISEASE; DRUG INDUCED TENDINOPATHY; FIBROBLAST; HEALING; HISTOGENESIS; HISTOLOGY; HUMAN; MUSCLE BLOOD FLOW; MUSCLE INNERVATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROSTAGLANDIN RELEASE; REVIEW; TENDINITIS; TENOBLAST; TENOCYTE; TISSUE DEGENERATION; ANATOMY AND HISTOLOGY; CHEMICALLY INDUCED; PHYSIOLOGY; RADIOGRAPHY; TENDINOPATHY; TENDON;

AROMATASE INHIBITORS; GLUCOCORTICOIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; QUINOLONES; TENDINOPATHY; TENDONS;

EID: 84922673002     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2014.03.022     Document Type: Short Survey

References (60)

1. Benjamin M., Newell R.L., Evans E.J., et al. The structure of the insertions of the tendons of biceps brachii, triceps and brachialis in elderly dissecting room cadavers. J Anat 1992, 180:327-332.
2. Kannus P., Józsa L., Natri A., et al. Effects of training, immobilization and remobilization on tendons. Scand J Med Sci Sports 1997, 7:67-71.
3. Elliott D.H. Structure and function of mammalian tendon. Biol Rev Camb Philos Soc 1965, 40:392-421.
4. Kirkendall D.T., Garrett W.E. Function and biomechanics of tendons. Scand J Med Sci Sports 1997, 7:62-66.
5. Theobald P., Benjamin M., Nokes L., et al. Review of the vascularisation of the human achilles tendon. Injury 2005, 36:1267-1272.
6. Maffulli N. Rupture of the Achilles tendon. J Bone Joint Surg Am 1999, 81:1019-1036.
7. Lephart S.M., Pincivero D.M., Giraldo J.L., et al. The role of proprioception in the management and rehabilitation of athletic injuries. Am J Sports Med 1997, 25:130-137.
8. Williams J.G. Achilles tendon lesions in sport. Sports Med 1993, 16:216-220.
9. Dallaudière B., Lempicki M., Pesquer L., et al. Efficacy of intra-tendinous injection of platelet-rich plasma in treating tendinosis: comprehensive assessment of a rat model. Eur Radiol 2013, 23:2830-2837.
10. Yu J.S., Popp J.E., Kaeding C.C., et al. Correlation of MR imaging and pathologic findings in athletes undergoing surgery for chronic patellar tendinitis. AJR Am J Roentgenol 1995, 165:115-118.
11. Stone D., Green C., Rao U., et al. Cytokine-induced tendinitis: a preliminary study in rabbits. J Orthop Res 1999, 17:168-177.
12. Wang M.X., Wei A., Yuan J., et al. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem Biophys Res Commun 2001, 284:667-673.
13. Birch H.L., Rutter G.A., Goodship A.E. Oxidative energy metabolism in equine tendon cells. Res Vet Sci 1997, 62:93-97.
14. Peerbooms J.C., Sluimer J., Bruijn D.J., et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010, 38:255-262.
15. Bleakney R.R., White L.M. Imaging of the Achilles tendon. Foot Ankle Clin 2005, 10:239-254.
16. Insall J., Salvati E. Patella position in the normal knee joint. Radiology 1971, 101:101-104.
17. Morvan G., Vuillemin-Bodaghi V., Mathieu P., et al. Normal and abnormal imaging of the foot's extensor system. J Radiol 2007, 88:143-155.
18. Zanetti M., Metzdorf A., Kundert H.P., et al. Achilles tendons: clinical relevance of neovascularization diagnosed with power Doppler US. Radiology 2003, 227:556-560.
19. Rosenberg Z.S., Beltran J., Bencardino J.T. From the RSNA refresher courses. Radiological Society of North America. MR imaging of the ankle and foot. Radiographics 2000, 20. [Spec No: S153-79].
20. Schweitzer M.E., Karasick D. MR imaging of disorders of the Achilles tendon. AJR Am J Roentgenol 2000, 175:613-625.
21. Royer R.J., Pierfitte C., Netter P. Features of tendon disorders with fluoroquinolones. Therapie 1994, 49:75-76.
22. Williams R.J., Attia E., Wickiewicz T.L., et al. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med 2000, 28:364-369.
23. Mandell L., Tillotson G. Safety of fluoroquinolones: an update. Can J Infect Dis 2002, 13:54-61.
24. Khaliq Y., Zhanel G.G. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 2003, 36:1404-1410.
25. Kaleagasioglu F., Olcay E. Fluoroquinolone-induced tendinopathy: etiology and preventive measures. Tohoku J Exp Med 2012, 226:251-258.
26. Wise B.L., Peloquin C., Choi H., et al. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med 2012, 125:1228e23-1228e28.
27. Gold L., Igra H. Levofloxacin-induced tendon rupture: a case report and review of the literature. J Am Board Fam Pract 2003, 16:458-460.
28. Hayem G. Statins and muscles: what price glory?. Joint Bone Spine 2002, 69:249-251.
29. Chazerain P., Hayem G., Hamza S., et al. Four cases of tendinopathy in patients on statin therapy. Joint Bone Spine 2001, 68:430-433.
30. Marie I., Noblet C. Drug-associated tendon disorders: after fluoroquinolones. Here are statins!. Rev Med Interne 2009, 30:307-310. [In French].
31. Savvidou C., Moreno R. Spontaneous distal biceps tendon ruptures: are they related to statin administration?. Hand Surg 2012, 17:167-171.
32. de Oliveira L.P., Vieira C.P., Guerra Fda R., et al. Statins induce biochemical changes in the Achilles tendon after chronic treatment. Toxicology 2013, 311:162-168.
33. Marie I., Delafenêtre H., Massy N., et al. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature. Arthritis Rheum 2008, 59:367-372.
34. Blanco I., Krähenbühl S., Schlienger R.G. Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance data. Drug Saf 2005, 28:633-643.
35. Fardet L., Blanchon T., Perdoncini-Roux A., et al. [Internal medicine physicians' perception of frequency and impact of corticosteroid-induced adverse events]. Rev Med Intern 2009, 30:113-118. [In French].
36. Bunch T.J., Welsh G.A., Miller D.V., et al. Case report: acute spontaneous Achilles tendon rupture in a patient with giant cell arteritis. Ann Clin Lab Sci 2003, 33:326-328.
37. Newnham D.M., Douglas J.G., Legge J.S., et al. Achilles tendon rupture: an underrated complication of corticosteroid treatment. Thorax 1991, 46:853-854.
38. Kotnis R.A., Halstead J.C., Hormbrey P.J. Atraumatic bilateral Achilles tendon rupture: an association of systemic steroid treatment. J Accid Emerg Med 1999, 16:378-379.
39. Haines J.F. Bilateral rupture of the Achilles tendon in patients on steroid therapy. Ann Rheum Dis 1983, 42:652-654.
40. Lee H.B. Avulsion and rupture of the tendo calcaneus after injection of hydrocortisone. Br Med J 1957, 2:395.
41. Nichols A.W. Complications associated with the use of corticosteroids in the treatment of athletic injuries. Clin J Sport Med 2005, 15:370-375.
42. Coombes B.K., Bisset L., Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet 2010, 376:1751-1767.
43. Haraldsson B.T., Langberg H., Aagaard P., Zuurmond A.M., van El B., Degroot J., et al. Corticosteroids reduce the tensile strength of isolated collagen fascicles. Am J Sports Med 2006, 34:1992-1997.
44. Kennedy J.C., Willis R.B. The effects of local steroid injections on tendons: a biomechanical and microscopic correlative study. Am J Sports Med 1976, 4:11-21.
45. Andres B.M., Murrell G.A. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res 2008, 466:1539-1554.
46. Gill S.S., Gelbke M.K., Mattson S.L., et al. Fluoroscopically guided low-volume peritendinous corticosteroid injection for Achilles tendinopathy. A safety study. J Bone Joint Surg Am 2004, 86-A:802-806.
47. Piper S.L., Laron D., Manzano G., et al. A comparison of lidocaine, ropivacaine and dexamethasone toxicity on bovine tenocytes in culture. J Bone Joint Surg Br 2012, 94:856-862.
48. Vuillemin V., Guerini H., Bard H., et al. Stenosing tenosynovitis. J Ultrasound 2012, 15:20-28.
49. Howell A., Cuzick J., Baum M., et al. Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 2005, 365:60-62.
50. Coombes R.C., Hall E., Gibson L.J., et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004, 350:1081-1092.
51. Presant C.A., Bosserman L., Young T., et al. Aromatase inhibitor-associated arthralgia and/or bone pain: Frequency and characterization in non-clinical trial patients. Clin Breast Cancer 2007, 7:775-778.
52. Sestak I., Cuzick J., Sapunar F., et al. Risk factors for joint symptoms in patients enrolled in the ATAC trial: A retrospective, exploratory analysis. Lancet Oncol 2008, 9:866-872.
53. Crew K.D., Greenlee H., Capodice J., et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 2007, 25:3877-3883.
54. Liow R.Y., Tavares S. Bilateral rupture of the quadriceps tendon associated with anabolic steroids. Br J Sports Med 1995, 29:77-79.
55. Maravelias C., Dona A., Stefanidou M., et al. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 2005, 158:167-175.
56. Seynnes O.R., Kamandulis S., Kairaitis R., et al. Effect of androgenic-anabolic steroids and heavy strength training on patellar tendon morphological and mechanical properties. J Appl Physiol 2013, 115:84-89.
57. Scuderi A.J., Datz F.L., Valdivia S., et al. Enthesopathy of the patellar tendon insertion associated with isotretinoin therapy. J Nucl Med 1993, 34:455-457.
58. Bottomley W.W., Cunliffe W.J. Acute Achilles tendonitis following oral isotretinoin therapy for acne vulgaris. Clin Exp Dermatol 1992, 17:250-251.
59. De Ponti A., Viganò M.G., Taverna E., et al. Adhesive capsulitis of the shoulder in human immunodeficiency virus-positive patients during highly active antiretroviral therapy. J Shoulder Elbow Surg 2006, 15:188-190.
60. Rivoisy C., Jauréguiberry S., M'Bappe P., et al. Tenosynovitis as a possible feature of immune reconstitution syndrome during highly active antiretroviral treatment (HAART). Joint Bone Spine 2009, 76:550-552.